Formulations:
- Parenteral > General injections > IV: 500 µg in vial powder for injection
Indications:
- Malignant trophoblastic neoplasms of placenta
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Malignant neoplasms of kidney, except renal pelvis
- Rhabdomyosarcoma primary site
- Ewing sarcoma of bone and articular cartilage of unspecified sites
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Parenteral > General injections > IV: 500 µg in vial powder for injection
Indications:
- Malignant trophoblastic neoplasms of placenta
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Malignant neoplasms of kidney, except renal pelvis
- Rhabdomyosarcoma primary site
- Ewing sarcoma of bone and articular cartilage of unspecified sites
Source: EML workbook import